HCW Biologics annual current ratio
2020
2021
2022
2023
2024
2025
HCW Biologics Current Ratio Growth & History (HCWB)
HCW Biologics's current ratio was 0.11 for fiscal 2025.
View full HCW Biologics company overviewHCW Biologics annual current ratio history
| Fiscal year | Period ended | Current ratio | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | 0.11 | −0.08 | −43.61% |
| 2024 | 2024-12-31 | 0.19 | −0.54 | −73.73% |
| 2023 | 2023-12-31 | 0.73 | −10.79 | −93.65% |
| 2022 | 2022-12-31 | 11.52 | −5.91 | −33.91% |
| 2021 | 2021-12-31 | 17.44 | 5.30 | +43.68% |
| 2020 | 2020-12-31 | 12.14 | — | — |
HCW Biologics quarterly current ratio
Q4.20
Q2.21
Q3.21
Q4.21
Q1.22
Q2.22
Q3.22
Q4.22
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Current ratio | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | 0.06 | −0.05 | −43.35% |
| Q1 2026 | 2026-03-31 | 0.09 | 0.02 | +23.55% |
| Q4 2025 | 2025-12-31 | 0.11 | −0.08 | −43.61% |
| Q3 2025 | 2025-09-30 | 0.06 | −0.01 | −15.10% |
| Q2 2025 | 2025-06-30 | 0.11 | 0.01 | +5.03% |
| Q1 2025 | 2025-03-31 | 0.07 | −0.39 | −84.92% |
| Q4 2024 | 2024-12-31 | 0.19 | −0.54 | −73.73% |
| Q3 2024 | 2024-09-30 | 0.07 | −2.49 | −97.28% |
| Q2 2024 | 2024-06-30 | 0.10 | −4.26 | −97.64% |
| Q1 2024 | 2024-03-31 | 0.46 | −6.16 | −93.01% |
| Q4 2023 | 2023-12-31 | 0.73 | −10.79 | −93.65% |
| Q3 2023 | 2023-09-30 | 2.56 | −9.96 | −79.58% |
| Q2 2023 | 2023-06-30 | 4.36 | −25.89 | −85.58% |
| Q1 2023 | 2023-03-31 | 6.62 | −20.12 | −75.24% |
| Q4 2022 | 2022-12-31 | 11.52 | −5.91 | −33.91% |
| Q3 2022 | 2022-09-30 | 12.52 | −5.67 | −31.18% |
| Q2 2022 | 2022-06-30 | 30.26 | 27.85 | +1155.64% |
| Q1 2022 | 2022-03-31 | 26.74 | — | — |
| Q4 2021 | 2021-12-31 | 17.44 | 5.30 | +43.68% |
| Q3 2021 | 2021-09-30 | 18.19 | — | — |
| Q2 2021 | 2021-06-30 | 2.41 | — | — |
| Q4 2020 | 2020-12-31 | 12.14 | — | — |
HCW Biologics current ratio trends
Over the last five fiscal years, HCW Biologics's current ratio decreased from 12.14 to 0.11, a change of −12.03. The latest reported quarter, Q2 2026, shows 0.06.
About the metric
What the current ratio means
The current ratio compares short-term assets with obligations due within roughly one year. A higher ratio generally indicates more short-term balance-sheet coverage, but normal levels vary by industry and business model.
Calculation and source
How the current ratio is calculated
TickerStat calculates the current ratio as SEC-reported current assets divided by SEC-reported current liabilities for the same balance-sheet date. Periods without a positive current-liability value are omitted. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review HCW Biologics source filings ↗